These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 10948333)

  • 1. Low specificity of cytokeratin 19 mRNA expression in the peripheral blood cells from patients with ovarian tumors.
    Takano H; Okamoto A; Fukushima K; Ochiai K; Tanaka T
    Oncol Rep; 2000; 7(5):1023-5. PubMed ID: 10948333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detecting cytokeratin 19 mRNA in the peripheral blood cells of cervical cancer patients and its clinical-pathological correlation.
    Yuan CC; Wang PH; Ng HT; Li YF; Huang TS; Chen CY; Tsai LC; Shyong WY
    Gynecol Oncol; 2002 Apr; 85(1):148-53. PubMed ID: 11925135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RT-PCR amplification of CK19 mRNA in the blood of breast cancer patients: correlation with established prognostic parameters.
    Kahn HJ; Yang LY; Blondal J; Lickley L; Holloway C; Hanna W; Narod S; McCready DR; Seth A; Marks A
    Breast Cancer Res Treat; 2000 Mar; 60(2):143-51. PubMed ID: 10845277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative real-time RT-PCR detection for CEA, CK20 and CK19 mRNA in peripheral blood of colorectal cancer patients.
    Xu D; Li XF; Zheng S; Jiang WZ
    J Zhejiang Univ Sci B; 2006 Jun; 7(6):445-51. PubMed ID: 16691638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of circulating breast cancer cells in peripheral blood by a two-marker reverse transcriptase-polymerase chain reaction assay.
    Fabisiewicz A; Kulik J; Kober P; Brewczyńska E; Pieńkowski T; Siedlecki JA
    Acta Biochim Pol; 2004; 51(3):747-55. PubMed ID: 15448736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fine needle aspiration may shed breast cells into peripheral blood as determined by RT-PCR.
    Hu XC; Chow LW
    Oncology; 2000 Sep; 59(3):217-22. PubMed ID: 11053989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of reverse-transcriptase polymerase chain reaction (RT-PCR) for carcinoembryonic antigen, cytokeratin 19, and maspin in the detection of tumor cells in leukapheresis products from patients with breast cancer: comparison with immunocytochemistry.
    López-Guerrero JA; Gilabert PB; González EB; Sanz Alonso MA; Pérez JP; Talens AS; Oraval EA; de la Rubia Comos J; Boix SB
    J Hematother; 1999 Feb; 8(1):53-61. PubMed ID: 10192302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative correlation of cytokeratin 19 mRNA level in peripheral blood with disease stage and metastasis in breast cancer patients: potential prognostic implications.
    Wong IH; Yeo W; Chan AT; Johnson PJ
    Int J Oncol; 2001 Mar; 18(3):633-8. PubMed ID: 11179498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative relationship of the circulating tumor burden assessed by reverse transcription-polymerase chain reaction for cytokeratin 19 mRNA in peripheral blood of colorectal cancer patients with Dukes' stage, serum carcinoembryonic antigen level and tumor progression.
    Wong IH; Yeo W; Chan AT; Johnson PJ
    Cancer Lett; 2001 Jan; 162(1):65-73. PubMed ID: 11121864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of immunocytochemistry, reverse transcriptase polymerase chain reaction, and nucleic acid sequence-based amplification for the detection of circulating breast cancer cells.
    Lambrechts AC; Bosma AJ; Klaver SG; Top B; Perebolte L; van' t Veer LJ; Rodenhuis S
    Breast Cancer Res Treat; 1999 Aug; 56(3):219-31. PubMed ID: 10573113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells.
    Ruud P; Fodstad O; Hovig E
    Int J Cancer; 1999 Jan; 80(1):119-25. PubMed ID: 9935241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Levels of cytokeratin CK19 expression in mononuclear blood cells evaluated using a reverse PCR (RT-PCR)].
    López Guerrero JA; Bolufer P; Barragán E; Sanz Alonso M; Palau J; Sempere A; De la Rubia J; Bonanad S; Torregrosa MD
    Sangre (Barc); 1996 Dec; 41(6):441-6. PubMed ID: 9148421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular detection of disseminated tumor cells in the peripheral blood in patients with gastrointestinal cancer.
    Huang P; Wang J; Guo Y; Xie W
    J Cancer Res Clin Oncol; 2003 Mar; 129(3):192-8. PubMed ID: 12684893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular detection of cancer cells in the peripheral blood of patients with breast cancer: comparison of CK-19, CEA and maspin as detection markers.
    Stathopoulou A; Mavroudis D; Perraki M; Apostolaki S; Vlachonikolis I; Lianidou E; Georgoulias V
    Anticancer Res; 2003; 23(2C):1883-90. PubMed ID: 12820473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Real-time RT-PCR detection of CK19, CK7 and MUC1 mRNA for diagnosis of lymph node micrometastases in non small cell lung carcinoma.
    Saintigny P; Coulon S; Kambouchner M; Ricci S; Martinot E; Danel C; Breau JL; Bernaudin JF
    Int J Cancer; 2005 Jul; 115(5):777-82. PubMed ID: 15729695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of circulating breast cancer cells with multiple-marker RT-PCR assay.
    Hu XC; Chow LW
    Anticancer Res; 2001; 21(1A):421-4. PubMed ID: 11299772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system.
    Stathopoulou A; Gizi A; Perraki M; Apostolaki S; Malamos N; Mavroudis D; Georgoulias V; Lianidou ES
    Clin Cancer Res; 2003 Nov; 9(14):5145-51. PubMed ID: 14613993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of CK19, CK20 and EGFR mRNAs in peripheral blood of carcinoma patients: correlation with clinical stage of disease.
    Gradilone A; Gazzaniga P; Silvestri I; Gandini O; Trasatti L; Lauro S; Frati L; Aglianò AM
    Oncol Rep; 2003; 10(1):217-22. PubMed ID: 12469172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of occult breast cancer cells by amplification of CK19 mRNA by reverse transcriptase-polymerase chain reaction: role of surgical manipulation.
    Galán M; Viñolas N; Colomer D; Soler G; Muñoz M; Longarón R; Ventura PJ; Gascón P; Estapé J
    Anticancer Res; 2002; 22(5):2877-84. PubMed ID: 12530011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cytokeratin 19 mRNA in human lung cancer cell lines.
    Ueda Y; Fujita J; Bandoh S; Hojo S; Yamaji Y; Ohtsuki Y; Dobashi N; Takahara J
    Int J Cancer; 1999 Jun; 81(6):939-43. PubMed ID: 10362142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.